The Protein Binding of Phenytoin, Propranolol, Diazepam, and AL01576 (an Aldose Reductase Inhibitor) in Human and Rat Diabetic Serum Patrick J. McNamaraRobert A. BlouinRomulus K. Brazzell OriginalPaper Pages: 261 - 265
Epimerization Kinetics of Moxalactam in Frozen Solution Naofumi HashimotoTeruhisa IchihashiHideo Yamada OriginalPaper Pages: 266 - 271
Dissolution of lonizable Drugs in Buffered and Unbuffered Solutions Sadettin S. OzturkBernhard O. PalssonJennifer B. Dressman OriginalPaper Pages: 272 - 282
Development of a Radioreceptor Assay for the D2-Selective Dopamine Agonist N-0437 Kees EnsingDick A. BloemhofRokus A. de Zeeuw OriginalPaper Pages: 283 - 287
Potential Improvement in the Shelf Life of Parenterals Using the Prodrug Approach: Bacampicillin and Talampicillin Hydrolysis Kinetics and Utilization Time Ngoc-Anh T. NguyenLobna M. MortadaRobert E. Notari OriginalPaper Pages: 288 - 296
Thiol Reduction of 3′-Azidothymidine to 3′-Aminothymidine: Kinetics and Biomedical Implications Anthony L. HandlonNorman J. Oppenheimer OriginalPaper Pages: 297 - 299
Receptor-Mediated Magnetic Carriers: Basis for Targeting James M. GalloEmad Eldin Hassan OriginalPaper Pages: 300 - 304
Site Dependence of Absorption-Promoting Actions of Laureth-9, Na Salicylate, Na2EDTA, and Aprotinin on Rectal, Nasal, and Buccal Insulin Delivery Bruce J. AungstNancy J. Rogers OriginalPaper Pages: 305 - 308
Enhanced Membrane Permeability to Phenol Red by Medium-Chain Glycerides: Studies on the Membrane Permeability and Microviscosity Kazutaka HigakiMuneyoshi KatoHitoshi Sezaki OriginalPaper Pages: 309 - 312
Mass Balance and Dose Accountability in Percutaneous Absorption Studies: Development of a Nonocclusive Application System Daniel A. W. BucksHoward I. MaibachRichard H. Guy Note Pages: 313 - 315
Stereoselective Binding of Disopyramide to Plasma Proteins Luisa ValdiviesoKathleen M. GiacominiTerrence F. Blaschke Note Pages: 316 - 318
Serum Protein Binding of AL01576, a New Aldose Reductase Inhibitor Patrick J. McNamaraRobert A. BlouinR. K. Brazzell Note Pages: 319 - 321
Reply to “Assessment of Variance in Bioavailability Studies: Comments on the Article by McNamara et al.” by Carl M. Metzler. Jerome P. SkellyVinod P. ShahDonald J. Schuirmann Letter Pages: 322 - 322